Guide with Complete Solutions | NP Exit Exam Prep | Pass
Guaranteed - A+ Graded
Part One: Advanced Pathophysiology
(50 Questions)
Q1: A 68-year-old male with a 40 pack-year smoking history presents with progressive
dyspnea and chronic productive cough. Lung function tests reveal FEV₁/FVC < 0.70 and
decreased DLCO. Which pathophysiological mechanism best explains the predominant
structural change in his lungs?
A. Hypertrophy of bronchial smooth muscle with increased mucus gland size
B. Destruction of alveolar walls and loss of elastic recoil [CORRECT]
C. Thickening of the alveolar-capillary membrane with fibrosis
D. Bronchial wall inflammation with eosinophilic infiltration
Correct Answer: B
,Rationale: The presentation describes emphysema-predominant COPD, characterized by
destruction of alveolar walls and loss of elastic recoil, leading to decreased DLCO and
air trapping. Option A describes chronic bronchitis features (Reid index > 0.4) but
doesn't explain the reduced DLCO. Option C describes interstitial lung disease
pathophysiology. Option D describes asthma, which typically shows reversibility and
normal DLCO between attacks.
Q2: A 45-year-old female with systemic lupus erythematosus develops acute chest pain,
friction rub, and diffuse ST elevation on ECG. Which pathophysiological mechanism
underlies her condition?
A. Immune complex deposition in the coronary arteries causing vasculitis
B. Fibrinous inflammation of the visceral and parietal pericardium [CORRECT]
C. Antiphospholipid antibody-mediated thrombosis of coronary vessels
D. Myocardial infiltration by inflammatory cells causing direct myocyte damage
Correct Answer: B
Rationale: Acute fibrinous pericarditis in SLE results from inflammation of the
pericardial layers, producing the classic friction rub and diffuse ST elevation. Option A
describes coronary vasculitis, which would cause ischemic patterns, not diffuse ST
elevation. Option C causes thrombotic events, not acute pericarditis. Option D describes
myocarditis, which lacks the characteristic friction rub and ECG findings of pericarditis.
,Q3: In the pathogenesis of atherosclerosis, which cellular event marks the transition
from fatty streak to fibrous plaque?
A. Endothelial cell apoptosis and denudation
B. Smooth muscle cell migration from media to intima and extracellular matrix
deposition [CORRECT]
C. Neutrophil infiltration and release of elastases
D. Lymphocyte activation and granuloma formation
Correct Answer: B
Rationale: The transition to fibrous plaque involves smooth muscle cell migration,
proliferation, and collagen/elastin deposition, creating the fibrous cap. Option A
describes endothelial injury, the initial step, not progression. Option C describes
emphysema pathophysiology. Option D describes granulomatous inflammation seen in
conditions like sarcoidosis.
Q4: A patient with chronic kidney disease stage 4 develops secondary
hyperparathyroidism. Which pathophysiological mechanism drives this complication?
A. Direct toxic effect of uremic toxins on parathyroid tissue
, B. Decreased phosphate excretion leading to hypocalcemia and reduced vitamin D
activation [CORRECT]
C. Excessive calcium absorption from the gastrointestinal tract
D. Increased sensitivity of parathyroid cells to calcitonin
Correct Answer: B
Rationale: In CKD, decreased phosphate excretion leads to hyperphosphatemia, which
binds calcium causing hypocalcemia. Additionally, reduced renal mass decreases
1α-hydroxylase activity, lowering active vitamin D and reducing intestinal calcium
absorption—both stimulating PTH release. Option A is incorrect; uremic toxins don't
directly stimulate PTH. Option C is opposite of what occurs. Option D is incorrect;
calcitonin inhibits, not stimulates, parathyroid cells.
Q5: Which molecular mechanism best explains the "two-hit" hypothesis in the
development of familial retinoblastoma?
A. Two separate mutations in different oncogenes on the same chromosome
B. Inherited mutation in one RB1 allele followed by somatic mutation in the second
allele [CORRECT]
C. Simultaneous activation of both tumor suppressor genes and proto-oncogenes